Annual Statement of Changes in Beneficial Ownership (5)
January 13 2020 - 3:08PM
Edgar (US Regulatory)
[X]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ]
Form 3 Holdings Reported
[ ]
Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0362
Estimated average burden hours per response...
1.0
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Generous Diane | 2. Issuer Name and Ticker or Trading SymbolAMERICAN BIO MEDICA CORP [abmc] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
122 SMITH ROAD | 3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY) 12/31/2019 |
(Street)
KINDERHOOK, NY 12106
(City)
(State)
(Zip)
| 4. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any | 3. Trans. Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) |
Amount | (A) or (D) | Price |
Common Shares (1) | 10/10/2019 | | A | 37398 | A | $0.09 | 37398 | D | |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (MM/DD/YYYY) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
(A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Non-Statutory Stock Option (1) | $0.12 | 6/19/2015 | | J | 20000 | | 6/19/2016 | 6/19/2025 (3) | Common Shares | 20000 | $0.115 | 20000 | D | |
Non-Statutory Stock Option (1) | $0.15 | 6/24/2016 | | J | 20000 | | 6/24/2017 | 6/24/2026 (3) | Common Shares | 20000 | $0.15 | 20000 | D | |
Non-Statutory Stock Option (1) | $0.13 | 6/15/2017 | | J | 20000 | | 6/15/2018 | 6/15/2027 (3) | Common Shares | 20000 | $0.13 | 20000 | D | |
Non-Statutory Stock Option (1) | $0.1 | 6/21/2018 | | J | 20000 | | 6/21/2019 | 6/21/2028 (3) | Common Shares | 20000 | $0.1 | 20000 | D | |
Non-Statutory Stock Option (1) | $0.07 | 6/20/2019 | | J | 20000 | | 6/20/2020 (2) | 6/20/2029 (3) | Common Shares | 20000 | $0.07 | 20000 | D | |
Explanation of Responses: |
(1) | Previously reported on Form 4 |
(2) | Generous resigned from the Board of Directors effective January 7, 2020. Although the options were not fully vested as of the date of the resignation, the options will continue to vest as if such resignation did not occur, provided that Generous does not engage in any activity detrimental to the Company's interest. |
(3) | The Board of Directors does reserve the right to termination stock options with respect to any and all unexercised shares if Generous engages in any activity detrimental to the Company's interest. |
Remarks: 42,600 common shares previously indicated as indirectly owned by Generous ("common shares held FBO children") are no longer indirectly owned by Generous due to the age of such children. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Generous Diane 122 SMITH ROAD KINDERHOOK, NY 12106 | X |
|
|
|
Signatures
|
Diane Generous | | 1/13/2020 |
**Signature of Reporting Person | Date |
American Bio Medica (CE) (USOTC:ABMC)
Historical Stock Chart
From Mar 2024 to Apr 2024
American Bio Medica (CE) (USOTC:ABMC)
Historical Stock Chart
From Apr 2023 to Apr 2024